InflaRx (IFRX) Capital Expenditures (2016 - 2026)
InflaRx's Capital Expenditures was -$42,370 in Q2 2026, compared with -$17,236 a year earlier.
Powered by 
Analysis
InflaRx (IFRX) Capital Expenditures (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, InflaRx's Capital Expenditures was -$134.67 billion through Jun 30, 2026; for FY2025, it came in at -$130.71 billion.
- In earlier years, Capital Expenditures was -$50.09 billion in FY2024, -$87.26 billion in FY2023, -$165.68 billion in FY2022 and -$43,217 in FY2021.
- Quarterly Capital Expenditures has moved between -$165.68 billion (Q4 2022) and -$1,847 (Q3 2024) over five years.
- Per Business Quant data, IFRX's Capital Expenditures in the three quarters before Q2 2026 was -$11,083 (Q1 2026), -$134.67 billion (Q4 2025) and -$102,844 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | InflaRx | 104.63 Mn | -228.98 Mn | 2.74 Mn | -42,370.41 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42,370.41 |
| Mar 31, 2026 | -11,083.45 |
| Dec 31, 2025 | 266,960.58 |
| Sep 30, 2025 | -162,870.42 |
| Jun 30, 2025 | 40,885.25 |
| Mar 31, 2025 | -10,987.98 |
| Dec 31, 2024 | 82,135.45 |
| Sep 30, 2024 | -64,028.39 |
| Jun 30, 2024 | 47,791.19 |
| Mar 31, 2024 | -17,456.75 |
| Dec 31, 2023 | 136,689.56 |
| Sep 30, 2023 | -76,870.82 |
| Jun 30, 2023 | 33,450.67 |
| Mar 31, 2023 | -6,489.42 |
| Dec 31, 2022 | 183,949.58 |
| Sep 30, 2022 | -27,864.67 |
| Jun 30, 2022 | 18,733.25 |
| Mar 31, 2022 | -8,785.66 |
| Dec 31, 2021 | 68,030.81 |
| Sep 30, 2021 | -47,672.69 |
API Access
InflaRx Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();